measure-repository/SOPs/Translation/SOP-TRN-001-Translation-Linguistic-Validation.md

Standard Operating Procedure: Translation and Linguistic Validation of Clinical Outcome Measures

Document ID	SOP-TRN-001
Title	Translation and Linguistic Validation of Clinical Outcome Measures
Revision	1.0
Effective Date	[DATE]
Author	[AUTHOR]
Approved By	[APPROVER]
Department	Outcomes Research

---

1. Purpose

This procedure establishes requirements for translating and linguistically validating clinical outcome measures to ensure conceptual equivalence across languages and cultures while maintaining psychometric properties.

2. Scope

This procedure applies to:

• Translation of validated outcome measures into new languages
• Linguistic validation of existing translations
• Cultural adaptation for different regions
• All measure types (PRO, ClinRO, ObsRO, PerfO)

3. Responsibilities

3.1 Translation Project Manager

• Oversee translation process
• Select and manage translation vendors
• Coordinate with copyright holders
• Ensure adherence to ISPOR guidelines
• Maintain translation documentation

3.2 In-Country Coordinator

• Recruit local translators and reviewers
• Arrange cognitive debriefing sessions
• Provide cultural context and guidance
• Review translations for local appropriateness

3.3 Quality Manager

• Review translation methodology
• Ensure documentation completeness
• Verify copyright permissions
• Approve final translated versions

4. Definitions

Term	Definition
Source Language	The original language of the measure (typically English)
Target Language	The language into which the measure is being translated
Forward Translation	Translation from source to target language
Backward Translation	Translation from target language back to source language
Reconciliation	Process of resolving discrepancies between translations
Cognitive Debriefing	Qualitative interviews with target population to assess comprehension
Linguistic Validation	Process of ensuring translation maintains conceptual equivalence
Conceptual Equivalence	Same meaning and relevance across languages and cultures

5. Procedure

5.1 Pre-Translation Activities

5.1.1. Verify translation rights:

• Check license agreement for translation permissions
• Contact copyright holder for authorization
• Determine if official translations already exist
• Document translation approval in FRM-TRN-001

5.1.2. Assess target country/region:

• Identify target language and dialect
• Consider cultural differences affecting concepts
• Determine literacy level of target population
• Identify any regional variations needed

5.1.3. Obtain source materials:

• Current version of source measure
• Administration instructions
• Conceptual framework and item intent
• Previous translation memory if available
• Validation data for reference

5.1.4. Select translation methodology:

• Standard ISPOR methodology (most common)
• Copyright holder's proprietary process if required
• Other recognized methods (e.g., EORTC, WHO)

5.1.5. Assemble translation team:

• Forward translators (2 required)
• Backward translator (1 required)
• In-country reviewer
• Native speakers of both languages
• Healthcare/clinical expertise preferred

5.2 Forward Translation

5.2.1. Conduct independent forward translations:

• Two translators work independently
• Native speakers of target language
• Fluent in source language
• One "informed" (aware of measure purpose)
• One "uninformed" (naive to measure concepts)

5.2.2. Forward translation guidelines:

• Aim for conceptual rather than literal translation
• Maintain level of language (lay vs technical)
• Preserve recall period and response options
• Note any translation challenges or ambiguities
• Document rationale for translation choices

5.2.3. Document forward translations in FRM-TRN-002:

• Original item
• Translator 1 version
• Translator 2 version
• Translator notes and rationale

5.3 Reconciliation of Forward Translations

5.3.1. Convene reconciliation meeting:

• Both forward translators
• In-country reviewer
• Project manager (may be remote)

5.3.2. Review each item systematically:

• Compare translation versions
• Discuss differences and rationale
• Consider cultural appropriateness
• Select preferred translation or create synthesis
• Reach consensus on single forward translation

5.3.3. Document reconciliation:

• Final reconciled translation
• Rationale for choices made
• Unresolved issues for further review
• Record in FRM-TRN-002

5.4 Backward Translation

5.4.1. Conduct independent backward translation:

• Translator different from forward translators
• Native speaker of source language
• Fluent in target language
• "Uninformed" - not previously exposed to measure

5.4.2. Translate reconciled version back to source language:

• Translate without seeing original source version
• Note any items difficult to translate back
• Provide literal translation
• Document in FRM-TRN-003

5.4.3. Compare backward translation to original:

• Identify discrepancies
• Assess whether differences indicate translation problems
• Consider whether adjustments needed
• Minor wording differences acceptable if concept maintained

5.5 Harmonization Review

5.5.1. Conduct harmonization meeting:

• Translation team
• Project manager
• Clinical/outcomes expert
• Copyright holder representative if required

5.5.2. Review backward translation comparison:

• Identify items with poor backward translation
• Discuss whether forward translation needs revision
• Consider alternative translations
• Update forward translation as needed

5.5.3. Review across measure:

• Ensure consistent terminology throughout
• Check consistency of instructions and response options
• Verify formatting and layout match original
• Finalize translated version

5.5.4. Document harmonization decisions in FRM-TRN-004

5.6 Cognitive Debriefing

5.6.1. Prepare cognitive debriefing protocol:

• Semi-structured interview guide
• Probes for comprehension and interpretation
• Questions about acceptability and relevance
• Typically 5-8 participants from target population

5.6.2. Recruit appropriate participants:

• Representative of intended respondent population
• Native speakers of target language
• Range of ages, education levels, disease severity
• Geographic diversity if regional dialects exist

5.6.3. Conduct cognitive debriefing interviews:

• Participant completes measure
• Interview about specific items:
  • "What does this question mean to you?"
  • "How did you decide on your answer?"
  • "Is anything confusing or difficult to understand?"
  • "Are any words or phrases unclear?"
• Probe problematic items in depth
• Document participant feedback

5.6.4. Analyze cognitive debriefing results:

• Identify items with comprehension problems
• Determine whether issues are widespread or isolated
• Assess whether revisions needed
• Document in FRM-TRN-005

5.7 Translation Revision (if needed)

5.7.1. If cognitive debriefing identifies problems:

• Convene translation team
• Develop alternative translations for problematic items
• Consider cultural adaptation if needed
• Document rationale for revisions

5.7.2. Conduct additional cognitive debriefing:

• Test revised items with new participants
• Continue until no significant issues identified
• Typically 5 participants per iteration sufficient

5.8 Proofreading and Finalization

5.8.1. Independent proofreading:

• Native speaker not involved in translation
• Check spelling, grammar, punctuation
• Verify consistency throughout
• Compare to source for formatting

5.8.2. Format final translation:

• Match layout of original measure
• Ensure readability (font size, spacing)
• Include all instructions and response options
• Add translation identification (language, version, date)

5.8.3. Create final translation package:

• Translated measure
• Administration instructions (translated)
• Scoring instructions (if publicly available)
• Translation certificate
• Linguistic validation report

5.9 Copyright Holder Review (if required)

5.9.1. Submit translation for approval:

• Final translated measure
• Translation methodology documentation
• Linguistic validation report summary
• Cognitive debriefing results

5.9.2. Address any copyright holder feedback:

• Make required revisions
• Document changes and rationale
• Obtain final approval

5.9.3. File approval in license documentation

5.10 Translation Documentation

5.10.1. Compile linguistic validation report:

• Translation methodology used
• Team qualifications
• Forward and backward translation results
• Cognitive debriefing findings
• Revisions made and rationale
• Conclusions regarding conceptual equivalence

5.10.2. Create translation certificate including:

• Source and target languages
• Measure name and version
• Translation completion date
• Certification that ISPOR guidelines followed
• Signatures of translation team lead and project manager

5.10.3. Archive all translation documentation:

• All translation versions
• Meeting notes and reconciliation records
• Cognitive debriefing transcripts and summaries
• Linguistic validation report
• Copyright holder correspondence
• File in Translation Database (FRM-TRN-006)

5.11 Cultural Adaptation

5.11.1. When cultural adaptation needed beyond translation:

• Identify culture-specific concepts requiring adaptation
• Consult with local clinical and cultural experts
• Modify items while maintaining conceptual equivalence
• Consider alternative examples or phrases
• Document all adaptations and justification

5.11.2. For substantial cultural adaptations:

• Consider conducting psychometric validation
• May require copyright holder approval
• May result in "culturally adapted version" designation

5.12 Electronic Format Considerations

5.12.1. For eCOA implementations:

• Verify text fits within screen space
• Check for right-to-left language considerations
• Test all navigation and response capture
• Ensure proper character encoding
• Validate against paper version

5.12.2. Document any format adaptations required

6. Related Documents

• FRM-TRN-001: Translation Authorization Form
• FRM-TRN-002: Forward Translation Documentation
• FRM-TRN-003: Backward Translation Documentation
• FRM-TRN-004: Harmonization Meeting Notes
• FRM-TRN-005: Cognitive Debriefing Summary
• FRM-TRN-006: Translation Database
• FRM-TRN-007: Translation Certificate Template
• SOP-LIC-001: License Management
• SOP-VAL-002: Cross-Cultural Validation

7. References

• Wild D, et al. (2005). Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health, 8(2), 94-104
• Wild D, et al. (2009). Multinational trials - recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report
• FDA (2009). Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
• Acquadro C, et al. (2008). Literature Review of Methods to Translate Health-Related Quality of Life Questionnaires for Use in Multinational Clinical Trials. Value in Health, 11(3), 509-521

---

Revision History

Rev	Date	Description	Author
1.0	[DATE]	Initial release	[AUTHOR]